The FDA Approved Eli Lilly's Diabetes Drug. But the Most Exciting Market May Be Something Else.

Retrieved on: 2022-05-14 16:21:40

Tags for this article:

Health

Life Sciences

Eli Lilly

Indiana Historical Society

Diabetes

Clinical trial

Eli Lilly and Company

Click the tags to see associated articles and topics

The FDA Approved Eli Lilly's Diabetes Drug. But the Most Exciting Market May Be Something Else.. View article details on hiswai:

Excerpt

His price target is $369. After Lilly's earnings report, BMO Capital Markets analyst Evan Seigerman wrote that tirzepatide was the star of Lilly's ...

Article found on: www.barrons.com

View Original Article